C4 Therapeutics, Inc. (CCCC)
3.755
+0.02
(+0.40%)
USD |
NASDAQ |
Sep 04, 16:00
3.755
0.00 (0.00%)
After-Hours: 20:00
C4 Therapeutics Cash and Short Term Investments (Annual) : 248.54M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 248.54M |
| December 31, 2024 | 244.90M |
| December 31, 2023 | 253.68M |
| December 31, 2022 | 276.15M |
| Date | Value |
|---|---|
| December 31, 2021 | 309.28M |
| December 31, 2020 | 371.69M |
| December 31, 2019 | 90.55M |
| December 31, 2018 | 36.31M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Beam Therapeutics, Inc. | 1.245B |
| Rallybio Corp. | 54.74M |
| Q32 Bio, Inc. | 48.30M |
| Arrowhead Pharmaceuticals, Inc. | 919.37M |
| Oncolytics Biotech, Inc. | 5.202M |